Castle Biosciences Castle Biosciences Acquires Cernostics for up to $80M Cernostics specializes in spatial biology and artificial intelligence-driven image analysis of tissue biopsies. Castle Biosciences Receives New York State Approval for DecisionDx DiffDx-Melanoma Test The gene expression profile assay is meant to aid dermatopathologists in characterizing difficult-to-diagnose melanocytic lesions. Castle Biosciences Awarded VA Supply Contract for Melanoma Test The company said the contract will provide greater access to its DecisionDx-Melanoma gene expression profile test for veterans and active duty military. Castle Biosciences Q2 Revenues Rise 79 Percent The company said it delivered 70 percent more DecisionDx-Melanoma test results year over year, and that the total number of all tests delivered more than doubled. People in the News: New Appointments at Castle Biosciences, Oxford Nanopore, PGDx, More Jun 9, 2021 Castle Biosciences Receives NYS DOH Approval for Skin Cancer Diagnostic May 14, 2021 People in the News: New Appointments at Berkeley Lights, Castle Bio, IsoPlexis, More May 11, 2021 Castle Biosciences to Expand Range of Dermatology Diagnostics Beyond Cancer Premium May 10, 2021 Castle Biosciences Q1 Revenues Up 31 Percent Apr 27, 2021 Castle Biosciences Acquires Myriad Genetics' MyPath Melanoma Test, Lab for $32.5M Apr 16, 2021 People in the News: New Appointments at ACMG, InterVenn Biosciences, Castle Biosciences, More Mar 8, 2021 Castle Biosciences Q4 Revenues Down 2 Percent Jan 4, 2021 GenomeWeb Index Ends 2020 on Upswing With Pacific Biosciences in Lead Dec 23, 2020 In Brief This Week: Natera, Sync for Genes, Castle Biosciences, BioMérieux, PathogenDx, More Dec 16, 2020 Castle Biosciences Prices $232M Public Offering of Common Stock Dec 3, 2020 Local Coverage Determinations Roundup: Castle Bio Nov 9, 2020 Castle Biosciences Q3 Revenues Up 3 Percent Nov 6, 2020 Medicare Administrative Contractor CGS Aligns Coverage for Melanoma Risk Stratification Tests Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 8, 2020 Castle Bio Receives Expanded Medicare Coverage for Melanoma Test Sep 4, 2020 People in the News: New Appointments at Castle Biosciences, Akoya Biosciences, Syapse, More Aug 10, 2020 Castle Biosciences Q2 Revenues Up 18 Percent Jun 25, 2020 Castle Biosciences Prices $74M Public Offering May 11, 2020 Castle Biosciences Doubles Q1 Revenues Apr 3, 2020 People in the News: Kim Popovits, Miles Harrison, Matt Sargent, More Load More Breaking News SUPER Psychosis Study Presented at ASHG Digs Into Relationships of Rare Variants, Phenotypes People in the News: New Appointments at Myriad Genetics, Becton Dickinson, Delfi Diagnostics, More In Brief This Week: Virginia Commonwealth University, Dovetail Genomics, Lucid Diagnostics, and More New Products Posted to GenomeWeb: Bio-Rad, PerkinElmer, Ares Genetics, Purigen Biosystems, More Genetron Health, Fosun Ink Commercialization Deal for Seq-MRD Test in China MultiMuTHER Team Tracks Expression, Metabolite Relationships in Aging TwinsUK Participants The Scan More Boosters for US Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes. From a Pig A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports. For Privacy's Sake Wired reports that more US states are passing genetic privacy laws. Science Paper on How Poaching Drove Evolution in African Elephants In Science this week: poaching has led to the rapid evolution of tuskless African elephants.